SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13G
                                 (Rule 13d-102)
             Information Statement Pursuant to Rules 13d-1 and 13d-2
                    Under the Securities Exchange Act of 1934

                        ALGOS PHARMACEUTICAL CORPORATION
                                (Name of Issuer)

                     COMMON STOCK, PAR VALUE $.01 PER SHARE
                         (Title of Class of Securities)

                                   015869 10 0
                                 (CUSIP Number)

                                Page 1 of 5 pages











                                       13G

CUSIP NO.      015869 10 0
               -----------

1.      NAME OF REPORTING PERSON:

                Michael Hyatt

2.      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

                                                                         (A) [ ]
                                                                         (B) [ ]

3.      SEC USE ONLY

4.      CITIZENSHIP OR PLACE OF ORGANIZATION:

                 United States citizen

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:

5.      SOLE VOTING POWER:

                                       842,501

6.      SHARED VOTING POWER:

                                       343,060

7.      SOLE DISPOSITIVE POWER:

                                       842,501

8.      SHARED DISPOSITIVE POWER:

                                       343,060

9.      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:

                                     1,185,561

10.     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES:

                                       [ ]

11.     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9:

                                                               7.7%

12.     TYPE OF REPORTING PERSON:

                               IN


                                Page 2 of 5 pages







Item 1.         (a) Name of Issuer: Algos Pharmaceutical Corporation

                (b) Address of Issuer's Principal Executive Offices:

                      Collingwood Plaza, 4900 Route 33
                      Neptune, New Jersey  07753-6804

Item 2.         (a) Name of Person Filing: Michael Hyatt

                (b) Address of Principal Business Office:

                      Algos Pharmaceutical Corporation
                      Collingwood Plaza, 4900 Route 33
                      Neptune, New Jersey  07753-6804

                (c) Citizenship: United States

                (d) Title of Class of Securities:

                          Common Stock, $.01 par value

                (e) CUSIP Number: 015869 10 0

Item 3. Not applicable.

Item 4. OWNERSHIP

                (a) Amount Beneficially Owned:  1,185,561

                (b) Percent of Class:  7.7%

                (c) Number of shares as to which such person has:

                    (i) sole power to vote or to direct the vote:

                                               842,501

                    (ii) shared power to vote or to direct the vote:

                                               343,060

                    (iii) sole power to dispose or to direct the disposition of:

                                               842,501

                    (iv)  shared  power to dispose or to direct the  disposition
                          of:

                                               343,060

                                Page 3 of 5 pages






ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:

               Not applicable.

ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:

               Of the shares reported by Mr. Hyatt, 363,810 shares are held in
               three trusts for which Mr. Hyatt serves as trustee and as to
               which Mr. Hyatt holds either the sole or shared power of
               disposition of the power to vote.

ITEM 7.  IDENTIFICATION  AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
         SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:

               Not applicable.

ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:

               Not applicable.

ITEM 9. NOTICE OF DISSOLUTION OF GROUP:

               Not applicable.

ITEM 10. CERTIFICATION:

               Not applicable.

                                Page 4 of 5 pages






                                    SIGNATURE

               After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.

Date:   February 18, 1997

                                        /s/ Michael Hyatt
                                            Michael Hyatt





                                Page 5 of 5 pages